Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow BIO-RAD LABORATORIES, INC.

Get SEC filing alerts via email and in your feed for BIO-RAD LABORATORIES, INC.

BIO BIO-B

BIO-RAD LABORATORIES, INC.

About BIO-RAD LABORATORIES, INC.

Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products globally. Its Life Science segment offers instruments, reagents, and consumables for biological material analysis, serving research institutions, biopharma, and food safety markets. The Clinical Diagnostics segment provides integrated test systems and reagents for clinical laboratories worldwide. Bio-Rad’s business model emphasizes innovation, direct sales, and recurring revenue from consumables tied to installed diagnostic systems.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from BIO-RAD LABORATORIES, INC.

1
1
BIO-RAD LABORATORIES, INC. Bio-Rad Laboratories Reports Q1 2026 Financial Results with Net Sales of $592.1 Million

Via official filing (AI summary) | about 1 month ago | 0 comments

2
1
BIO-RAD LABORATORIES, INC. Bio-Rad Laboratories Reports Modest Revenue Increase and Significant Net Income Turnaround for Fiscal Year 2025

Via official filing (AI summary) | 4 months ago | 0 comments

3
1
BIO-RAD LABORATORIES, INC. Bio-Rad Laboratories Reports Q3 2025 Financial Results with Net Loss of $341.9 Million

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
BIO-RAD LABORATORIES, INC. Bio-Rad Laboratories Reports $317.8M Net Income in Q2 2025, Completes Stilla Technologies Acquisition

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
BIO-RAD LABORATORIES, INC. Bio-Rad Laboratories Reports 4.2% Decline in Q1 2025 Net Sales

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
BIO-RAD LABORATORIES, INC. Bio-Rad Laboratories Reports Mixed Q3 2024 Results, Net Sales Up 2.8% Year-Over-Year

Via official filing (AI summary) | over 1 year ago | 0 comments